<DOC>
	<DOCNO>NCT02866357</DOCNO>
	<brief_summary>To assess infective etiology quantitative polymerase chain reaction ( qPCR ) acute exacerbation COPD asthma require hospitalization . To identify HRV subtypes associate COPD asthmaexacerbations . To assess infective aetiology association clinical outcome patient .</brief_summary>
	<brief_title>Respiratory Pathogens Patients With Asthma COPD Exacerbations</brief_title>
	<detailed_description>Objective : Chronic obstructive pulmonary disease ( COPD ) asthma exacerbation contribute significant health care burden . Viral infection important cause acute exacerbation COPD asthma . Hypothesis test : 1 . Assess infective etiology Multiplex Molecular Detection nasopharyngeal aspirate ( NPA ) patient acute exacerbation COPD asthma ; 2 . Identify human rhinovirus ( HRV ) ( common virus cause exacerbation ) subtypes involve ; 3.Assess infective etiology association clinical outcome patient . Design subject : Prospective observational study . Patients admit hospital acute exacerbation COPD asthma . Stable COPD asthma patient recruit control . Study instrument : Multiplex Molecular Detection respiratory pathogen NPA . Clinical data patient collect spirometry performed . Interventions : NPA collection subject . Main outcome measure : Primary aim assessment prevalence different virus relation acute exacerbation asthma COPD . Secondary aim ass certain pathogen associate clinical outcome include duration hospitalization 30 60 day readmission mortality Data analysis : Data analyze Statistical Package Social Science Statistical software Window , Version 22 ( IBM SPSS Inc , IL , USA ) . Statistical method include chi-square test , student test ANOVA use appropriate . Expected result : Understanding epidemiology respiratory virus COPD asthma exacerbation allow investigation treatment option give information prognosis .</detailed_description>
	<criteria>For COPD patient , patient admit Prince Wales Hospital AECOPD screen study . AECOPD define patient background COPD ( lung function parameter FEV1/FVC ratio &lt; 70 % ) 24 present least two follow major symptom ( increased dyspnoea , increase sputum purulence , increase sputum volume ) one major one minor symptom ( nasal discharge/congestion , wheeze , sore throat , cough ) least two consecutive days.25,26 Inclusion criterion : 1 . Patients background COPD mention fulfil exacerbation criterion 2 . Age ≥40 year For asthma patient , patient admit Prince Wales Hospital asthma exacerbation screen study . Acute exacerbation asthma define asthma patient present increase dyspnea , wheeze cough . Inclusion criterion : 1 . Patients background asthma ( defined consistent history prior document evidence variable airflow obstruction , evidence increase FEV1 great 12 % 400 mL follow bronchodilator bronchial hyperresponsiveness bronchial provocation testing , stable ) 6 exacerbation criterion least 2 consecutive day . 2 . Age ≥18 year Control asthma COPD subject recruit respiratory clinic Prince Wales Hospital . Subjects match age , sex lung function COPD asthma subject . All recruit COPD subject FEV1/FVC ratio &lt; 70 % . For asthma patient , clinical diagnosis asthma ( defined consistent history prior document evidence variable airflow obstruction , evidence increase FEV1 great 12 % 400 mL follow bronchodilator bronchial hyperresponsiveness bronchial provocation testing , stable ) . These subject exacerbation asthma COPD 6 week prior assessment . Exclusion criteria patient : 1 . History lung resection significant pulmonary disease like pulmonary fibrosis . 2 . Active infection like pulmonary tuberculosis 3 . Unable complete assessment due physical and/or cognitive impairment 4 . Having short life expectancy like subject terminal malignancy intractable heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>